cro.directory
← Compare landing

Avigen Ltd vs IPM Biotech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/avigen/ipmbiotech

CategoryAvigen LtdIPM Biotech
Listed sitecrocro
SummaryAvigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications.IPM Biotech (生创精准医疗科技有限公司) is a cell technology and regenerative medicine company founded in 2015 by a team of renowned returnee scientists specializing in stem cells and regenerative medicine.
Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • Translational Research
  • Clinical Trial Services
  • Protein Engineering
  • Discovery Research
Modalities
  • Cell Therapy
  • Cell Therapy
Indications
  • Oncology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
Locations
  • White City (Scale Space), London, United Kingdom
  • Headquarters, Hangzhou, Zhejiang, China
  • Xiaoshan Office, Hangzhou, Zhejiang, China
  • Gongshu Office, Hangzhou, Zhejiang, China
  • Zhoushan Facility, Zhoushan, Zhejiang, China
  • Boao Facility, Qionghai, Hainan, China
  • Bangkok Facility, Bangkok, Bangkok, Thailand
  • Chongqing, Chongqing, Chongqing, China
  • Jinan, Jinan, Shandong, China
  • Zhengzhou, Zhengzhou, Henan, China
  • Hong Kong, Hong Kong, Hong Kong, Hong Kong
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.